Neptune strengthens balance sheet
This article was originally published in The Tan Sheet
Laval, Quebec, Canada-based Neptune Technologies & Bioresources announces Nov. 24 it has conducted a private placement of common shares to raise $4.5 mil. and accelerate its development for Neptune Krill Oil. Neptune President and CEO Henri Harland says the offering enhances the company's balance sheet, which strengthens the firms negotiations regarding the product. "The derivatives from Neptune Krill Oil as a functional health ingredient for cognitive and joint health in the health food market and for the management of cardiovascular disease as a prescription drug have attracted great interest from corporations," he says...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.